It is estimated that 60–70% of individuals with classical manifestations of Gorlin syndrome harbor germline pathogenic variants in the PTCH1 gene, with most of these variations leading to a loss of protein function. This evidence concerns the gene PTCH1 and nevoid basal cell carcinoma syndrome.